Australia markets close in 3 hours 30 minutes

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
32.80-0.35 (-1.06%)
At close: 04:00PM EDT
32.80 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.58B
Enterprise value 3.95B
Trailing P/E 39.05
Forward P/E 9.94
PEG ratio (5-yr expected) 0.83
Price/sales (ttm)1.71
Price/book (mrq)1.62
Enterprise value/revenue 2.56
Enterprise value/EBITDA 15.44

Trading information

Stock price history

Beta (5Y monthly) 1.14
52-week change 3-44.17%
S&P500 52-week change 323.42%
52-week high 359.30
52-week low 332.50
50-day moving average 337.85
200-day moving average 340.15

Share statistics

Avg vol (3-month) 3651.2k
Avg vol (10-day) 3606.39k
Shares outstanding 578.6M
Implied shares outstanding 678.22M
Float 867.22M
% held by insiders 113.81%
% held by institutions 188.65%
Shares short (28 Mar 2024) 42.09M
Short ratio (28 Mar 2024) 42.27
Short % of float (28 Mar 2024) 43.08%
Short % of shares outstanding (28 Mar 2024) 42.66%
Shares short (prior month 29 Feb 2024) 42.51M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 304 Jan 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.39%
Operating margin (ttm)19.12%

Management effectiveness

Return on assets (ttm)4.24%
Return on equity (ttm)3.99%

Income statement

Revenue (ttm)1.54B
Revenue per share (ttm)19.25
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)N/A
EBITDA 383.57M
Net income avi to common (ttm)67.74M
Diluted EPS (ttm)0.84
Quarterly earnings growth (yoy)-62.50%

Balance sheet

Total cash (mrq)309.1M
Total cash per share (mrq)3.95
Total debt (mrq)1.68B
Total debt/equity (mrq)106.02%
Current ratio (mrq)3.45
Book value per share (mrq)20.31

Cash flow statement

Operating cash flow (ttm)139.96M
Levered free cash flow (ttm)177.7M